
09/26/2025
Now Enrolling in Owensboro & Evansville and Coming Soon to Bowling Green!
A phase III clinical trial to assess the effect of an investigational medicine on major adverse cardiovascular events in patients with established Atherosclerotic Cardiovascular Disease (ASCVD) or at high risk for a first ASCVD event is enrolling.
Call 270-685-4589, or register online for more information at:
https://qualmedicaresearch.com/dyslipidemia-ascvd-and-elevated-ldl-trial/